Valuation

CAHCardinal Health

StockNYSEUnited StatesHealth careEU retail investors: available

+0.9% today · +35.9% over a year

7/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 84% of the instruments we score

Stability: among the best of its peers; priced lower than most peers. Dividend yield 0.75%.

Cardinal Health (CAH) valuation against sector peers: P/E 37.0 (sector median 30.9), EV/EBIT 25.9, free-cash-flow yield 7.1%, P/S 0.2.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricCAHSector medianvs median
P/E37.030.9 · n=15920% above
P/B—4.0 · n=307—
P/S0.24.1 · n=29994% below
EV/EBIT25.925.6 · n=146near the median
Free-cash-flow yield7.1%1.4% · n=288394% above
Dividend yield0.75%0.00% · n=362—
Return on equity—−2.1% · n=308—
Return on invested capital135.8%0.6% · n=28220,961% above
Gross margin3.8%63.3% · n=20594% below
Net debt / EBITDA1.131.27 · n=15111% below

Value factor: 77 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

LLYEli Lilly & Co48.233.0—1.5%0.6%6/10
JNJJohnson & Johnson42.28.3—3.0%1.9%8/10
ABBVAbbVie50.3—27.73.6%2.9%6/10
MRKMerck149.58.2—4.0%2.3%8/10
UNHUnitedHealth22.43.417.16.4%2.3%10/10
TMOThermo Fisher Scientific37.84.935.72.8%0.3%9/10
AMGNAmgen26.817.523.23.8%2.1%8/10
GILDGilead Sciences—16.1—6.6%1.9%5/10
ABTAbbott40.73.832.93.5%2.8%6/10
PFEPfizer41.31.9—7.1%7.4%1/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Jun 2026 · filed 05 Nov 2026